It was noteworthy that gene subtype B had a higher risk score than gene subtype A. Furthermore, Figure 5D showed the distribution of scores in two costimulatory molecule subtypes, where AML patients in the costimulatory molecule subtype B group had significantly higher scores than others in the costimulatory molecule subtype A group. The gene discussed is CD276; the disease is acute myeloid leukemia.